The World Congress on Treatment and Research in MS took place recently. At this important MS meeting there were scientific oral presentations and posters; this meeting is important because it updates all of us clinicians and scientists on the latest and greatest in the MS world. There is presentation of laboratory research, but mostly there are... Read more
MS is about so much more than two letters, an MRI and needles.
It’s about families; it’s about working together; it’s about forging new relationships; it’s about getting to know yourself better and getting to know your community better.
Each of us in the MS community uses our resources to improve the community as a whole.... Read more
We talk a lot about the treatment of relapsing-remitting MSM but we really want to develop more treatment options for progressive MS.
Dirucotide (MBP8298) is being studied in clinical trials for the treatment of secondary progressive MS (SPMS) at 68 sites with approximately 510 patients. The FDA has given fast track status because of the... Read more
I
have noticed a trend in our monthly MS Town Hall Meetings: Despite (or maybe
because of) the potential risks involved with the newer medicines, people want
to talk about symptom management and not necessarily the fancy new disease
modifying agents.
Those
of you who have read previous blogs know that there are three arms of... Read more
We are getting closer the release of the first oral
medicines in the treatment of Relapsing-Remitting MS (RRMS) with the goal of
preventing relapses (and hopefully progression and disability). Altruistic patients
worldwide are taking part in multiple clinical trials testing the safety and
efficacy (effectiveness) of these new forms of... Read more